Fenwick & West LLP represented DexCare,Inc. in the transaction. DexCare, Inc. announced the close of its $75 million Series C funding round led by ICONIQ Growth...
DexCare’s $75 Million Series C Financing
DexCare’s $50 Million Series B Financing
Fenwick & West advised DexCare on the deal. DexCare, a data-driven intelligence company focused on healthcare access, announced its $50 million Series B financing. The round was...